{"composite_breakdown_label":"","computation_units":"","copyright":"","data_footnote":"","data_non_statistical":false,"data_notice_class":"","data_notice_heading":"","data_notice_text":"","data_show_map":false,"data_start_values":[],"embedded_feature_footer":"","embedded_feature_html":"","embedded_feature_tab_title":"","embedded_feature_title":"","embedded_feature_url":"","expected_disaggregations":[],"graph_annotations":[],"graph_limits":[],"graph_stacked_disaggregation":"","graph_title":"global_indicators.3-b-1-title","graph_titles":[],"graph_type":"line","indicator_name":"global_indicators.3-b-1-title","indicator_number":"3.b.1","national_geographical_coverage":"","page_content":"","permalink":"","precision":[],"reporting_status":"notstarted","sort":"","standalone":false,"tags":[],"SDG_GOAL":"<p>Goal 3: Ensure healthy lives and promote well-being for all at all ages</p>","SDG_TARGET":"<p>Target 3.b: Support the research and development of vaccines and medicines for the communicable and non&#x2011;communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all</p>","SDG_INDICATOR":"<p>Indicator 3.b.1: Proportion of the target population covered by all vaccines included in their national programme</p>","STAT_CONC_DEF":"<p><strong><em>Coverage of DTP containing vaccine (3<sup>rd</sup> dose)</em></strong><em>:</em> Percentage of surviving infants who received the 3 doses of diphtheria and tetanus toxoid with pertussis containing vaccine in a given year.</p>","DATA_COMP":"","REC_USE_LIM":"","SDG_GOAL__GLOBAL":"<p>Goal 3: Ensure healthy lives and promote well-being for all at all ages</p>","SDG_TARGET__GLOBAL":"<p>Target 3.b: Support the research and development of vaccines and medicines for the communicable and non&#x2011;communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all</p>","SDG_INDICATOR__GLOBAL":"<p>Indicator 3.b.1: Proportion of the target population covered by all vaccines included in their national programme</p>","fr":{"SDG_GOAL":"<p>Objectif 3 : Permettre \u00e0 tous de vivre en bonne sant\u00e9 et promouvoir le bien-\u00eatre de tous \u00e0 tout \u00e2ge.</p>","SDG_TARGET":"<p>Cible 3.b: Appuyer la recherche et le d\u00e9veloppement de vaccins et de m\u00e9dicaments contre les maladies, transmissibles ou non, qui touchent principalement les habitants des pays en\u00a0d\u00e9veloppement, donner acc\u00e8s, \u00e0 un co\u00fbt abordable, aux\u00a0m\u00e9dicaments et vaccins essentiels, conform\u00e9ment \u00e0 la\u00a0D\u00e9claration de Doha sur l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC) et la sant\u00e9 publique, qui r\u00e9affirme le droit qu\u2019ont les pays en d\u00e9veloppement de tirer pleinement parti des dispositions de cet accord qui m\u00e9nagent une flexibilit\u00e9 lorsqu\u2019il s\u2019agit de prot\u00e9ger la sant\u00e9 publique et, en particulier, d\u2019assurer l\u2019acc\u00e8s universel aux m\u00e9dicaments</p>","SDG_INDICATOR":"<p>Indicateur 3.b.1: Proportion de la population cible ayant re\u00e7u tous les vaccins pr\u00e9vus par le programme national</p>","STAT_CONC_DEF":"<p><strong><em> Couverture du vaccin contenant le DTC (3 <sup> rd </sup> dose) </em></strong><em> : </em> Pourcentage de nourrissons survivants ayant re\u00e7u les 3 doses de vaccin contenant l'anatoxine dipht\u00e9rique et t\u00e9tanique contre la coqueluche au cours d'une ann\u00e9e donn\u00e9e. </p>","DATA_COMP":"","REC_USE_LIM":"","SDG_GOAL__GLOBAL":"<p>Objectif 3 : Permettre \u00e0 tous de vivre en bonne sant\u00e9 et promouvoir le bien-\u00eatre de tous \u00e0 tout \u00e2ge.</p>","SDG_TARGET__GLOBAL":"<p>Cible 3.b: Appuyer la recherche et le d\u00e9veloppement de vaccins et de m\u00e9dicaments contre les maladies, transmissibles ou non, qui touchent principalement les habitants des pays en\u00a0d\u00e9veloppement, donner acc\u00e8s, \u00e0 un co\u00fbt abordable, aux\u00a0m\u00e9dicaments et vaccins essentiels, conform\u00e9ment \u00e0 la\u00a0D\u00e9claration de Doha sur l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC) et la sant\u00e9 publique, qui r\u00e9affirme le droit qu\u2019ont les pays en d\u00e9veloppement de tirer pleinement parti des dispositions de cet accord qui m\u00e9nagent une flexibilit\u00e9 lorsqu\u2019il s\u2019agit de prot\u00e9ger la sant\u00e9 publique et, en particulier, d\u2019assurer l\u2019acc\u00e8s universel aux m\u00e9dicaments</p>","SDG_INDICATOR__GLOBAL":"<p>Indicateur 3.b.1: Proportion de la population cible ayant re\u00e7u tous les vaccins pr\u00e9vus par le programme national</p>","reporting_status":"notstarted"},"national_metadata_updated_date":"2021-11-05","national_metadata_update_url_text":"2021-11-05: see changes on GitHub","national_metadata_update_url":"https://github.com/sdg-data-canada-odd-donnees/sdg-data-donnees-odd/commit/816d237ee0033b31305b52abfd18dc5f1286102d","indicator":"3.b.1","target_id":"3.b","sdg_goal":"3","indicator_sort_order":"03-0b-01"}